Instadiag, diagnosis in one day

InstaDiag Skin

A treatment pathway designed to expedite care for locally advanced or metastatic skin carcinomas

InstaDiag Peau Project Leader: 
Dr. Belkadi-Sadou Djaouida 

Instadaig logo

Skin carcinomas are the most common types of skin cancer. When they are locally advanced or metastatic, their management requires prompt specialized evaluation and the coordination of multiple medical specialties.

InstaDiag Peau is an innovative care pathway that draws on Gustave Roussy’s recognized expertise in the management of complex, advanced, and rare skin cancers.

InstaDiag Skin—what is it?

InstaDiag Skin draws on Gustave Roussy’s expertise in complex skin carcinomas. This care pathway brings together the various specialists involved within a tight timeframe to accurately assess the disease and quickly determine the appropriate course of treatment.

It schedules the necessary consultations and tests, whenever possible, all on the same day.

Depending on the specific situation, dermatologists, oncologists, surgeons, radiologists, interventional radiologists, nuclear medicine physicians, pathologists, cytologists, and radiation oncologists may be involved in the care pathway. The patient is thus supported by a multidisciplinary team with the goal of quickly obtaining a comprehensive understanding of their condition and guiding them toward the most appropriate treatment strategy

A coordinated care pathway, multidisciplinary expertise, and personalized care

  • 1 day

    To consolidate, as much as possible, the consultations and tests required for the evaluation

  • A multidisciplinary team

    The necessary expertise is mobilized and coordinated around the patient

  • Within 15 days

    The results are discussed at a multidisciplinary team meeting to determine the treatment plan

Who is InstaDiag Peau intended for?

InstaDiag Skin is intended for patients with skin carcinoma (basal cell carcinoma, cutaneous squamous cell carcinoma) that is locally advanced (deep invasion) or metastatic (lymph node or deep organ involvement) and requires rapid specialized evaluation, as well as all patients with Merkel cell neuroendocrine carcinoma of the skin.
This pathway addresses complex cases in which multiple expert opinions or additional tests are required before a treatment plan can be determined.

  • 1. Before You Arrive

    Your medical records are reviewed to plan your care pathway

    The results of any previous biopsies and imaging studies, medical reports, medical history, and current treatments—which will be provided in advance—will allow the team to plan for the necessary evaluations and tests. 

  • 2. InstaDiag Day

    You’ll meet the specialists best suited to your situation

    The process includes a dermatological evaluation and, when indicated, a surgical or radiation therapy consultation. Any tests already performed are reviewed to avoid unnecessary procedures. 

  • 3. Targeted Exams

    The evaluation is tailored to your needs

    Blood tests, lymph node ultrasound with fine-needle aspiration, CT scans, MRIs, PET scans, and skin, lymph node, or deep tissue biopsies may be recommended depending on the situation. Some tests require some time to obtain results. 

  • 4. A Joint Decision

    Your case is reviewed by several specialists

    The results are presented at a multidisciplinary consultation meeting to determine the most appropriate treatment strategy. 

Frequently Asked Questions

Schedule an appointment for InstaDiag Skin

The InstaDiag Skin pathway is intended for patients with locally advanced or metastatic skin carcinoma who require a rapid specialized evaluation. If your situation meets the criteria for this pathway, you may submit a request for an appointment along with your available medical records so that the teams can evaluate your request and arrange the necessary tests.

Hall d'accueil

Bibliography

[1] National Cancer Institute. Epidemiology of Skin Cancers. Updated May 28, 2026.
[2] French National Authority for Health. Joint INCa-HAS Guideline, Cutaneous Squamous Cell Carcinoma: Diagnostic and Therapeutic Management. Posted online on July 8, 2010. https://www.has-sante.fr
[3] Gustave Roussy. Skin Cancer, Treatment.